GENENTECH INC

DC

Pharmaceutical company

Active 2007–2026. The register lists this client once for every firm that files on its behalf; all 32 of its records are shown together here.

Filings
1,035
Filed By
32
Reported In-House
$121,259,095
Reported By Firms
$37,679,000

These two figures are not added together. A client that lobbies for itself reports its own spending, while firms it retains report what they were paid. Disclosure rules ask the in-house figure to include those payments, but filings do not always do so, and a filing gives no way to tell. Each is shown as reported.

Filings

YearFirmPeriodAmountDoc
2008 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 2nd Quarter (Apr 1 - June 30)
AMENDED
$50,000
2008 RYAN MACKINNON VASAPOLI AND BERZOK, LLP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$50,000
2008 CAPITOL COUNSEL LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$20,000
2008 CAUTHEN FORBES & WILLIAMS 4th Quarter (Oct 1 - Dec 31)
AMENDED
$30,000
2008 THE FRANKLIN PARTNERSHIP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$30,000
2008 PODESTA GROUP, INC. 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$60,000
2008 FOLEY HOAG LLP 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$30,000
2008 POLARIS GOVERNMENT RELATIONS, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$10,000
2008 WILLIAMS AND JENSEN, PLLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$50,000
2008 KADESH & ASSOCIATES, LLC 4th Quarter (Oct 1 - Dec 31)
4th Quarter - Report
$45,000
Page 1 of 8  ·  72 filings Next
Filed By
Issue Areas

Bills Mentioned in Filings